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ABSTRACT Subventricular zone (SVZ) cells proifferate
spontaneously in vivo in the telencephalon of adult mammals.
Several studies suggest that SVZ cells do not differentiate after
mitosis into neurons or glia but die. In the present work, we
show that SVZ cells labeled in the brains of adult mice with
[3H]thymidine differentiate directly into neurons and glia in
explant cultures. In vitro labeling with [3H]thymidine shows
that 98% of the neurons that differentiate from the SVZ
explants are derived from precursor cells that underwent their
last division in vivo. This report identifies the SVZ cells as
neuronal precursors in an adult mammalian brain.
Neurons are born in the ventricular and subventricular zone
(SVZ) of the developing central nervous system. In mam-
mals, this is a process that ends before or soon after birth (1,
2). Adult neurogenesis in the mammalian brain has been
described only in the dentate gyrus of the hippocampus and
olfactory bulb (3-6). However, in these cases newly gener-
ated neurons are not born in the ventricular zone or SVZ but
are thought to be derived from precursor cells located within
these regions (3-6). In contrast, the brain of the adult bird
retains the ability to generate neurons in the ventricular zone
ofthe forebrain (7, 8). Interestingly, the brains ofadult mouse
(9), rat (10), dog (11), and monkey (12) retain a population of
proliferating cells in the SVZ. These proliferating cells are
located in the walls of the lateral ventricle in a region where
neurons and glia are born during late stages of embryonic
development (1). Recent experiments suggest that the prog-
eny of SVZ cells in adult mice do not differentiate into
neurons or glia in vivo; instead, it has been hypothesized that
one daughter cell dies while the other one reenters mitosis
(13). Recent works show that cells dissociated from adult
mouse brain can be stimulated to proliferate in vitro when
epidermal growth factor (EGF) (14) or basic fibroblast growth
factor (bFGF) (15) is added to the culture medium, and under
appropriate conditions the progeny of these dividing cells
differentiate into neurons and glia. In the present work, we
label cells in the SVZ of adult mice with [3H]thymidine and
show that these cells, which divide in vivo, differentiate in
vitro into neurons and glia. These experiments indicate that
the SVZ of the adult mammalian brain retains the potential to
generate new neurons.
MATERIALS AND METHODS
[3H]Thymidine Labeling in Vivo. Adult male mice (CD-1;
3-8 months old) received 5 i.p. injections of 50 ,uCi (6.7
Ci/mmol; 1 Ci = 37 GBq; NEN) of [3H]thymidine every 12
hr.
Histology. Mice (n = 2) were deeply anesthetized with
sodium pentobarbital (Nembutal) (6 hr after the last [3H]thy-
midine injection) and perfused with 3.7% paraformaldehyde
in 0.1 M phosphate buffer (PB) (pH 7.3), and the brains were
processed for autoradiography as described (8). Sections
were mapped to determine position, number, and phenotype
of labeled cells.
SVZ Explant Cultures. Mice (n = 5) received [3H]thymi-
dine in vivo as described above and were sacrificed by
cervical dislocation 6 hr after the last injection. This time was
chosen so that no [3H]thymidine would be present in the
extracellular fluids (16). The SVZ was dissected from a
frontal slice (=2 mm thick) extending between the crossing of
the anterior commissure and the rostral opening of the third
ventricle. A strip of tissue (=100 ,tm wide; 2-4 mm long) was
cut along the lateral wall of the lateral ventricle under the
corpus callosum down to the ventral tip of the lateral ven-
tricle (Fig. 1). Tissue was minced with scalpels into pieces of
=0.15 mm. Explants were cultured onto 35-mm dishes coated
with poly-(D-lysine) (50 ,ug per 100 mm2) containing 500 ul of
culture medium. Each animal yielded 100-120 explants that
were plated at a density of 30 explants per dish. The medium
composition was as follows: 50% Dulbecco's modified Ea-
gle's medium (GIBCO), 25% Earle's balanced salt solution
(GIBCO), 25% donor horse serum (JRH Biosciences, Len-
exa, KS), 1 mM glutamine (GIBCO), penicillin (50 units/ml),
streptomycin (50 ,ug/ml), amphotericin (0.125 ,ug/ml)
(GIBCO), and glucose (6 mg/ml) (Sigma). Explants were
cultured at 36°C in a 7% CO2/93% air atmosphere. Twenty-
four hours after plating, 200 ,ul of medium was added to each
of the dishes, and after 48 hr in vitro all the medium was
replaced with 700 ,ul offresh medium. The cultures were fixed
after 6 days in vitro (DIV).
Cortex and Striatum Cultures. Mice (n = 5) received
[3H]thymidine in vivo as described above. Explants from
striatum and cortex were obtained from the regions indicated
in Fig. 1 and were processed as described for the SVZ.
In Vitro [3H]Thymidine Labeling. Mice (n = 2) were killed
and the SVZ was dissected as described above. Culture
medium (as described above) was supplemented with
[3H]thymidine (1 ACi/ml) for labeling dividing cells. Cultures
were exposed to [3H]thymidine either for the first 2 DIV or
during the last 4 DIV. Similar results were obtained irrespec-
tive of the time when [3H]thymidine was present and data
were pooled from these two groups. [3H]Thymidine is met-
abolically active to label the dividing cells in vitro during
periods longer than 6 days (16).
Immunocytochemistry and Autoradiography of Cultures.
After 6 DIV, explant cultures were washed for 5 min with
Dulbecco's phosphate-buffered saline (DPBS) supplemented
with CaCl2 (0.1 g/liter) fixed for 10 min with 3.7% parafor-
maldehyde in PBS (pH 7.3), and washed three times with PBS
Abbreviations: SVZ, subventricular zone; EGF, epidermal growth
factor; bFGF, basic fibroblast growth factor; DIV, days in vitro;
BSA, bovine serum albumin; MAP-2, microtubule-associated pro-
tein 2; NF, neurofilament; NSE, neuron-specific enolase; GFAP,
glial fibrillary acidic protein.
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FIG. 1. (A) Dark-field photomicrograph of a frontal section (6 ,um
thick) of adult mouse SVZ. After [3H]thymidine treatment in vivo (as
described below), most of the labeled cells are concentrated in the
SVZ (white spots are [3H]thymidine-labeled nuclei). V, lateral ven-
tricle; Sp, septum; St, striatum. (Bar = 100 ,um.) (B) Schematic
diagram of a frontal section of mouse brain showing the dissected
regions (boldface dotted lines). Dotted rectangle corresponds to the
area shown in A. cc, Corpus callosum.
(5 min each). Cells were permeabilized with 0.25% Triton
X-100 in PBS for 5 min and subsequently incubated with a
solution containing 10% (wt/vol) bovine serum albumin
(BSA) (Sigma). After 20 min, this solution was removed and
the explants were incubated for 24 hr at 4°C with mouse
monoclonal antibodies against microtubule-associated pro-
tein 2 (MAP-2) (Sigma; M4403) (dilution, 1:500), 200-kDa
neurofilament (NF) (Sigma; N5389) (dilution, 1:100), rabbit
polyclonal antiserum against neuron-specific enolase (NSE)
(Polysciences; 16625) (dilution, 1:3000), and glial fibrillary
acidic protein (GEAP) (a gift of L. Eng, Stanford University)
(dilution, 1:100). These primary antibodies were diluted in a
solution containing 3% BSA in PBS. Tissue culture dishes
were rinsed three times (5 min each) with PBS and incubated
with biotinylated horse monoclonal antibody against mouse
IgG (dilution, 1:200 in PBS/3% BSA) for 1 hr at room
temperature. After three washes with PBS (5 min each), the
explants were incubated with an avidin-biotin solution
(Vectastain Elite, Vector Laboratories) (1 drop ofA reagent
plus 1 drop of B reagent diluted in 5 ml of DPBS) for 30 min
at room temperature. The dishes were washed three times
with PBS (5 min each) and incubated for 4 min in a solution
containing 0.2 mg of diaminobenzidine per ml and 0.01%
H202 in PBS. Omission ofthe primary antibody resulted in no
detectable staining. Culture dishes were covered with auto-
radiographic emulsion (Kodak NTB2) and incubated at 4°C
for 15 days. Autoradiograms were developed in D19 (Kodak)
at 17°C.
RESULTS
Proliferating cells in the adult mouse brain, as revealed by
[3H]thymidine labeling (16, 17), were restricted almost com-
pletely (>98% of all labeled cells per section) to the walls of
the lateral ventricle in the SVZ (Fig. 1). [3H]Thymidine-
labeled cells outside of the SVZ had the morphology of glial
or endothelial cells.
To test the potential fates of these dividing cells, the SVZ
was isolated and cultured. Explants of the SVZ attached to
the substrate within several hours after plating. During the
first 2 DIV, few cells migrated out of the explant. By 6 DIV,
the explants had generated an outgrowth consisting of flat
glial cells (positive to GFAP) and birefringent cells growing
Proc. Natl. Acad. Sci. USA 90 (1993) 2075
on top of the glial monolayer (Fig. 2). The birefringent cells
had one or more processes that grew longer with time (Fig.
2). Birefringent multipolar cells were more frequent after
several DIV. These process-bearing cells were neurons as
defined by positive immunostaining with antibodies specific
for MAP-2, NF, and NSE (18, 19) and absence of staining
with antibodies against GFAP.
Explants stained with neuron-specific antibodies were
processed for autoradiography to detect the presence of
[3H]thymidine in the cell nuclei (Fig. 1). Microscopic exam-
ination ofculture dishes revealed that the majority ofneurons
(84.38%) in the outgrowth surrounding an explant were
labeled with [3H]thymidine (Table 1). Many of the flat glial
cells in the outgrowth were also [3H]thymidine positive. The
overall ratio of [3H]thymidine-labeled glia to neurons was 1:1,
but individual explants displayed significant variations from
this ratio. These results indicate that cells that were prolif-
erating in the adult SVZ in vivo had the potential for gener-
ating neurons and glial cells. However, we do not know
whether individual precursor cells from the SVZ can generate
both cell types.
Control explants obtained from cortex or striatum exclud-
ing the SVZ were cultured and processed in the same way as
the SVZ explants. No [3H]thymidine-labeled cells could be
detected in any of these control experiments. In contrast to
A
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FIG. 2. Phase-contrast photomicrographs of live explants from
striatum (A) and SVZ (B) after 5 DIV. SVZ explant generates an
extensive outgrowth while a typical explant from striatum generates
no outgrowth. (C) Outgrowth from a SVZ explant after fixation and
immunocytochemical staining with MAP-2 monoclonal antibody.
Neurons migrate throughout the outgrowth, differentiate, and extend
processes on top of the glial monolayer. Position of explant that
detached during staining is indicated by an e. (Bars = 100 pm.)
ti. .4:T.
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the sequence of events observed in SVZ explants, cortical
and striatal explants never generated an outgrowth area (Fig.
2). A small number of glial cells (one to three per explant)
emerged from some of the control explants and remained in
the immediate vicinity of the explants, but these cells were
negative to [3H]thymidine. These results indicate that in our
culture conditions the SVZ tissue sampled, but not cortex or
striatum, was able to generate neurons and glial cells.
To test whether the neuronal precursor cells from the SVZ
continued to divide in vitro, explants were exposed to
[3H]thymidine in culture (Fig. 3 and Table 1). A large number
of the glial cells throughout the outgrowth were heavily
labeled with autoradiographic grains over their nuclei when
[3H]thymidine was present in the culture medium. This
indicates that glial cells continue to divide in vitro. In
contrast, in this same experiment, 17 neurons of 897 neurons
counted (1.93%) were labeled with [3H]thymidine. The av-
erage number of neurons per explant was similar whether the
culture medium contained or lacked [3H]thymidine, indicat-
ing that the presence of [3H]thymidine in vitro did not
influence the differentiation or survival of neurons. These
results indicate that the vast majority of neurons differenti-
ating in culture were derived from precursor cells that
underwent their last division in vivo.
DISCUSSION
The results presented here suggest that SVZ cells that divide
spontaneously in vivo give rise to cells that differentiate into
neurons or glia in culture. Recently, it has been reported that
cells isolated from adult mouse brains can be stimulated to
proliferate in vitro when EGF or bFGF is added to the culture
medium, and under appropriate conditions the progeny of
these dividing cells differentiate into neurons and glia (14,
15). In these previous studies, the brain was dissociated into
single cells. This procedure did not allow characterizing the
identity and location ofthe growth factor-responsive cells. In
the present work, we labeled the SVZ cells in vivo and show
that the daughter cells can become neurons in vitro. The SVZ




Table 1. [3H]Thymidine-labeled cells in explant cultures
SVZ Cortex Striatum
[3H]- [3H1- [3H]- [3H]-
Thymidine Thymidine thymidine thymidine
in vivo in vitro in vivo in vivo
Cultured explants -600 -200 -600 -600
Productive explants '15% "15% --2%9 '2%
Mapped explants 57 16 11 15
Labeled glia 2789 1776 0 0
Labeled neurons 2576 17 0 0
Total neurons 3042 897 0 0
% neurons
labeled 84.38% 1.93%
Explants were mapped under high-magnification objective (x63)
with the aid of a computer-based mapping microscope. Cells were
considered to be [3H]thymidine labeled when their nuclei were
overlaid by five or more silver grains (>20 times background).
Neurons were identified by MAP-2-, NSE-, or NF-positive staining.
Numbers refer to total number of cells of the different categories in
all the explants mapped.
bFGF in the in vitro conditions reported by other authors (14,
15), but this is still not known. Previous reports could be
dealing with a completely different set of cells, which are
normally dormant in the brain and are induced to proliferate
when exposed to mitogens in vitro. Here we show that the
progeny of SVZ stem cells differentiate in culture directly
into neurons and glia after having completed their last divi-
sion in the brain. SVZ cells do not have to divide in vitro in
order to generate neurons. In sum, we show that the SVZ
contains a population of neural stem cells that divide in adult
mammalian brains and have the potential to differentiate
directly into neurons and glia.
In our culture conditions, glial cells continued to divide in
vitro but most neuronal precursors did not. We also observed
that after [3H]thymidine labeling of the SVZ cells in vivo,
approximately an equal number of labeled neurons and
labeled glial cells appeared in the cultures after 6 DIV. These
observations suggest that the labeled SVZ cells initially
B





FIG. 3. (A and C) Photomicrographs show cells in focus. (B and D) Photomicrographs show autoradiographic grains in focus overlying the
same cells shown in A and C. Most of the neurons (identified by MAP-2 staining; small arrows in A) are labeled by [3H]thymidine treatment
in vivo as revealed by autoradiographic grains overlaying their nuclei (B). Glial cells are also labeled by [3H]thymidine treatment in vivo (large
arrow in A). In vitro treatment with [3H]thymidine results in many heavily labeled glial cells that appear as large clusters of autoradiographic
grains (D), but neurons (C) are not labeled (arrows in D). (Bars = 50 ,um.)
Proc. NatL Acad. Sci. USA 90 (1993)
.40: 04b
Proc. Natl. Acad. Sci. USA 90 (1993) 2077
generated more neurons than glial cells. However, other
interpretations are also possible (e.g., the glial cells may have
diluted the label after several rounds of proliferation), and it
is difficult at this point to explain the ratio of neurons to glia
that we showed arose from dividing SVZ cells. It will be of
interest to determine the lineage dynamics of differentiation
of adult SVZ cells.
In adult birds, new neurons continue to be generated in
proliferating regions in the lateral wall of the lateral ventricle,
a region topographically equivalent to the SVZ of mammals
(8, 20). Explant cultures derived from the adult avian ven-
tricular zone also generated neurons in vitro from precursors
that divided in vivo (21). However, in adult birds young
neurons migrate away from their birth site throughout the
telencephalon to differentiate into neurons in vivo (20). These
new neurons integrate into functional circuits in the brain
(22). It has been hypothesized that neurogenesis in adult birds
may be used as a form of plasticity for learning (23).
In the early postnatal period SVZ cells of mammals gen-
erate glial cells (1). It has been speculated that some SVZ
cells may serve as a source of glial cells in adulthood (see ref.
1, p. 427). However, there is no evidence that the SVZ in
adult mice generates neurons or glia in vivo. Instead, several
lines of evidence indicate that the SVZ cells die in vivo after
proliferation. There is a rapid decrease in the number of
[3H]thymidine or bromodeoxyuridine-labeled SVZ cells 3
days after injection (9, 13) and many pyknotic nuclei can be
found in the SVZ (9). Moreover, recent experiments in which
proliferating SVZ cells were labeled with recombinant ret-
roviruses show that clones of retrovirus-infected cells con-
tained only 1 or 2 cells and remain in the SVZ regardless of
the survival time after infection (13). Although some retro-
virally infected cells may fail to express the marker (see ref.
24), together these experiments (9, 13) are consistent with the
interpretation that in the adult rodent brain death is the fate
of half of the postmitotic SVZ cells.
We have shown that SVZ cells that divide in the brain
spontaneously can differentiate into neurons under culture
conditions. Perhaps dividing SVZ cells are retained as a
source of neurons or glial cells for unknown targets in the
brain or during environmental demands still to be identified
(25). Alternatively, stem cell proliferation in the SVZ may
have been retained as an evolutionary relic without function;
neurogenesis in adult mammals may have been discontinued
as part of an evolutionary process to ensure the stability of
circuits and perhaps memory (2). Understanding the cellular
and molecular mechanisms that control the proliferation and
fate of SVZ cells of adult mammals may lead to a further
understanding of the conditions that regulate these processes
and enable induction of neurogenesis in adult mammals.
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